AFP and hepatocellular carcinoma: The classic prognostic model, tumor‐node‐metastasis (TNM) staging, as well as molecular biomarkers such as serum alpha-fetoprotein (AFP) levels, have been utilized for the diagnosis of HCC and for predicting its prognostic outcome to therapy [7].